Stem-cell transplantation for children with primary immune deficiencies: A retrospective study of 19 patients from one centre in Mexico.

Aidé Tamara Staines-BooneMaría Guadalupe González-VillarealMaría Teresa Pompa-GarzaTeodoro Muñiz-RonquilloAdriana Carolina Sandoval-GonzálezDavid Muzquiz-ZermeñoMarco Antonio Padilla-CastroJorge Alberto García-CamposLuz María Sánchez-Sánchez Edna Venegas Montoya Saul Oswaldo Lugo-Reyes

Published in: Scandinavian journal of immunology (2022)

We describe 19 patients from Mexico with 8 PID diagnoses who underwent allogenic HSCT over a period of 11 years. Survival rate and other outcomes compare well with industrialized countries. We recommend the use of post-transplant cyclophosphamide to prevent GVHD in scenarios of resource scarcity and a lack of HLA-identical donors.

Keyphrases

stem cell transplantation
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
high dose
low dose
type diabetes
climate change
metabolic syndrome
patient reported outcomes
kidney transplantation